SPAC20G4.08 Antibody

What is SPAC20G4.08 and what biological functions does it serve?

SPAC20G4.08 is the systematic name for the gene sup11+ in Schizosaccharomyces pombe. This gene encodes Sup11p, a 582-amino acid protein that is essential for cell viability and proper septum formation during cell division. Functionally, Sup11p plays a crucial role in cell wall remodeling through interactions with glucan-modifying enzymes, particularly Gas2p (a β-1,3-glucanosyltransferase). The protein contains 20 leucine-rich repeats (LRRs) that are critical for mediating protein-protein interactions, allowing Sup11p to engage with various partners in the cell wall synthesis machinery. Research has shown that depletion of Sup11p leads to abnormal accumulation of β-1,3-glucan at the septum, ultimately disrupting cell wall architecture and compromising cell viability.

What are the key characteristics of antibodies against SPAC20G4.08/Sup11p?

SPAC20G4.08/Sup11p antibodies are typically developed as polyclonal antibodies by immunizing rabbits with recombinant Schizosaccharomyces pombe SPAC20G4.08 protein . These antibodies have the following characteristics:

• Form: Typically available in liquid form

• Storage Buffer: Usually preserved in 0.03% Proclin 300, 50% Glycerol, 0.01M PBS at pH 7.4

• Purification Method: Antigen affinity purified

• Isotype: IgG

• Clonality: Polyclonal

• Storage Requirements: -20°C to -80°C, with caution against repeated freezing

Polyclonal antibodies against Sup11p are commonly generated using GST-fusion peptides and subsequently affinity-purified to ensure specificity for the target protein.

What applications have been validated for SPAC20G4.08 antibodies?

SPAC20G4.08 antibodies have been validated for several experimental applications:

• Western Blotting (WB): Used to detect different isoforms of Sup11p, including hypo-glycosylated versus fully glycosylated forms, particularly in mutant strains

• Enzyme-Linked Immunosorbent Assay (ELISA): For quantitative detection of the protein in samples

• Immunofluorescence: For subcellular localization studies of Sup11p

• PAS-Silver Staining: Used in conjunction with antibody techniques to study glycosylation patterns of Sup11p

The antibody is particularly useful in studies examining cell wall integrity, septum formation, and protein glycosylation states in fission yeast.

How can I optimize western blotting protocols for detecting different glycosylation states of Sup11p?

Detecting different glycosylation states of Sup11p requires careful optimization of western blotting protocols:

• Sample Preparation:

  • Extract proteins using a lysis buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% NP-40, and protease inhibitors

  • Include phosphatase inhibitors if phosphorylation status is also of interest

  • For membrane proteins like Sup11p, consider adding 0.1% SDS to improve solubilization

• Gel Electrophoresis:

  • Use 8-10% SDS-PAGE gels to achieve optimal separation of differently glycosylated forms

  • For distinguishing subtle differences in glycosylation, consider using gradient gels (4-15%)

  • Load appropriate controls including wild-type samples and glycosylation-deficient mutants (e.g., oma4Δ strains)

• Transfer and Detection:

  • Semi-dry transfer at 15V for 30 minutes works well for most applications

  • Block with 5% non-fat milk in TBST for 1 hour at room temperature

  • Incubate with anti-SPAC20G4.08 antibody (1:1000 dilution) overnight at 4°C

  • Use secondary antibody (anti-rabbit IgG-HRP) at 1:5000 dilution for 1 hour at room temperature

• Specific Glycoform Detection:

  • To differentiate O-mannosylated versus N-glycosylated forms, perform parallel blots treated with PNGase F or O-glycosidase

  • The fully glycosylated Sup11p will appear at a higher molecular weight compared to hypo-mannosylated forms

How can I use SPAC20G4.08 antibody in combination with in silico antibody design tools for studying protein-protein interactions?

The integration of SPAC20G4.08 antibodies with in silico antibody design tools offers a powerful approach for studying protein-protein interactions:

• Initial Structural Analysis:

  • Use RosettaAntibody to generate 3D models of the antibody if crystal structures are unavailable

  • Apply RosettaRelax to minimize the energy of protein structures, making input conformations closer to bound states and increasing docking accuracy

• Two-Step Docking Approach:

  • Perform global docking first to identify potential binding interfaces between Sup11p and its interaction partners

  • Follow with local docking using SnugDock (https://rosie.graylab.jhu.edu/snug_dock) to refine the binding poses with flexibility of interfacial side chains and CDR loops

  • This approach is particularly valuable for studying interactions between Sup11p and glucan-modifying enzymes like Gas2p

• Alanine Scanning and Hotspot Identification:

  • Based on the refined antibody-antigen complex, perform computational alanine scanning

  • Mutate residues on the antibody-antigen interface to alanine and calculate energy changes

  • Identify hotspots that can guide further antibody design or provide insights into critical binding residues

• Experimental Validation:

  • Use SPAC20G4.08 antibody in competitive binding assays to validate computational predictions

  • Perform co-immunoprecipitation experiments to confirm predicted protein-protein interactions

  • Consider site-directed mutagenesis of identified hotspots to experimentally verify their importance

This integrated approach combines the specificity of SPAC20G4.08 antibodies with the predictive power of computational methods to enhance understanding of Sup11p's role in cell wall remodeling.

What are the optimal conditions for immunofluorescence microscopy using SPAC20G4.08 antibody to study septum formation?

For high-quality immunofluorescence microscopy using SPAC20G4.08 antibody to study septum formation:

• Cell Fixation and Permeabilization:

  • Fix cells with 3.7% formaldehyde for 30 minutes at room temperature

  • Permeabilize with 1% Triton X-100 in PBS for 2 minutes (crucial for accessing intracellular antigens)

  • For better preservation of septum structures, consider using a combination of formaldehyde and glutaraldehyde (3.7% and 0.2%, respectively)

• Blocking and Antibody Incubation:

  • Block with 1% BSA and 0.1% Tween-20 in PBS for 1 hour

  • Incubate with primary SPAC20G4.08 antibody at 1:100-1:200 dilution overnight at 4°C

  • Wash thoroughly with PBS (3×5 minutes)

  • Incubate with fluorophore-conjugated secondary antibody (such as goat anti-rabbit IgG Alexa Fluor 488) at 1:500 dilution for 1 hour at room temperature

• Co-staining for Comprehensive Analysis:

  • For cell wall visualization, co-stain with Calcofluor White (5 μg/mL) for 5 minutes

  • For septum-specific visualization, consider co-staining with BODIPY-conjugated anti-β-1,3-glucan antibodies

• Mounting and Imaging:

  • Mount slides using antifade mounting medium containing DAPI (1 μg/mL) for nuclear staining

  • Use confocal microscopy with appropriate filter sets for optimal visualization

  • For time-course studies of septum formation, collect z-stack images at 0.3 μm intervals

• Controls and Troubleshooting:

  • Always include a negative control (secondary antibody only) to assess background fluorescence

  • If high background is observed, increase blocking time or BSA concentration

  • For weak signals, try reducing permeabilization time or increasing antibody concentration

This protocol is particularly effective for visualizing the dynamic localization of Sup11p during cell division and its co-localization with cell wall components.

How can I analyze transcriptional changes associated with Sup11p depletion using SPAC20G4.08 antibody?

Analyzing transcriptional changes associated with Sup11p depletion requires a multifaceted approach incorporating SPAC20G4.08 antibody:

• Generation of Conditional Mutants:

  • Create a conditionally repressible sup11+ strain using thiamine-repressible promoters (nmt1)

  • Verify protein depletion by western blotting with SPAC20G4.08 antibody at defined time points after repression

  • Establish a depletion timeline to correlate protein levels with phenotypic changes

• RNA Extraction and Transcriptome Analysis:

  • Extract total RNA from cells at different depletion timepoints

  • Perform RNA-seq or microarray analysis to identify differentially expressed genes

  • Focus analysis on genes involved in cell wall biosynthesis, particularly glucanases like gas2+

• Validation of Transcriptional Changes:

  • Perform RT-qPCR to validate expression changes of key genes identified in transcriptome analysis

  • Use northern blotting for genes of particular interest

• Correlation with Protein Levels:

  • Use western blotting with SPAC20G4.08 antibody to correlate Sup11p depletion with transcriptional changes

  • Consider ChIP-seq experiments to identify potential direct regulatory targets if Sup11p is suspected to have transcriptional regulatory functions

• Functional Validation:

  • Based on transcriptome results, generate deletion or overexpression strains of differentially expressed genes

  • Assess genetic interactions through synthetic lethality or suppression analysis

  • Use SPAC20G4.08 antibody to analyze protein levels in these genetic backgrounds

This approach has previously revealed upregulated expression of glucanases (e.g., gas2+) in sup11 mutants, indicating compensatory cell wall remodeling mechanisms in response to Sup11p depletion.

How should I interpret differences in SPAC20G4.08 antibody binding patterns between wild-type and glycosylation-deficient strains?

Interpreting differences in antibody binding patterns between wild-type and glycosylation-deficient strains requires careful analysis:

• Pattern Analysis in Wild-Type Strains:

  • In wild-type cells, Sup11p typically undergoes O-mannosylation, resulting in a characteristic banding pattern on western blots

  • The predominant forms will be fully glycosylated, appearing at higher molecular weights

• Alterations in Glycosylation-Deficient Strains:

  • In O-mannosylation-deficient strains (e.g., oma4Δ), hypo-mannosylated forms of Sup11p will be observed

  • These forms may expose cryptic N-glycosylation sites (e.g., N-X-A sequons) that are normally masked by O-mannosylation

  • This leads to novel banding patterns that represent alternative glycosylation states

• Quantitative Assessment:

  • Use densitometry to quantify the relative abundance of different glycoforms

  • Calculate the ratio of fully glycosylated to hypo-glycosylated forms as a metric of glycosylation efficiency

  • Compare these ratios across different experimental conditions or genetic backgrounds

• Functional Correlation:

  • Correlate changes in glycosylation patterns with phenotypic observations (e.g., septum formation defects, cell wall integrity)

  • Use glycosidase treatments in combination with western blotting to specifically identify the types of glycosylation present

• Experimental Controls:

  • Include samples from multiple glycosylation-deficient strains (e.g., oma4Δ, pmr1Δ) to distinguish between effects specific to certain glycosylation pathways

  • Use purified recombinant Sup11p (with defined glycosylation states) as reference standards

This analytical approach allows researchers to gain insights into the complex post-translational regulation of Sup11p and its impact on cell wall remodeling functions.

What are the best practices for storing and handling SPAC20G4.08 antibody to maintain optimal activity?

To maintain optimal activity of SPAC20G4.08 antibody throughout your research:

• Storage Conditions:

  • Store antibody at -20°C or -80°C for long-term storage as recommended by suppliers

  • Avoid repeated freeze-thaw cycles, which can lead to protein denaturation and loss of activity

  • For antibodies in working dilutions, store at 4°C for up to one week

• Aliquoting Strategy:

  • Upon receipt, divide the antibody into small working aliquots before freezing

  • Calculate aliquot volumes based on typical experiment needs to minimize freeze-thaw cycles

  • Use sterile microcentrifuge tubes and aseptic technique when preparing aliquots

• Buffer Considerations:

  • Most SPAC20G4.08 antibodies are supplied in a buffer containing 50% glycerol, 0.01M PBS (pH 7.4), and 0.03% Proclin 300 as a preservative

  • This formulation enhances stability during freezing

  • Do not dilute the stock antibody unless immediately using for experiments

• Handling During Experiments:

  • Always keep the antibody on ice when in use

  • Return to appropriate storage conditions promptly after use

  • Use clean pipette tips and avoid contamination with other reagents

• Monitoring Antibody Performance:

  • Include positive controls in each experiment to monitor antibody performance over time

  • Keep detailed records of antibody performance to track any gradual loss of activity

  • Consider creating a standard curve with known quantities of target protein to quantify sensitivity

Following these best practices will help ensure consistent experimental results and maximize the useful life of your SPAC20G4.08 antibody.

How can I use SPAC20G4.08 antibody in studying the interplay between protein glycosylation and cell wall integrity?

Leveraging SPAC20G4.08 antibody to investigate the relationship between protein glycosylation and cell wall integrity requires a multifaceted approach:

• Glycosylation State Analysis:

  • Use western blotting with SPAC20G4.08 antibody to identify different glycosylation states of Sup11p

  • Employ glycosidase treatments (PNGase F, O-glycosidase) followed by western blotting to characterize specific modifications

  • Apply PAS-silver staining in parallel to visualize total glycoprotein patterns

• Structure-Function Correlation:

  • Create targeted mutations in potential glycosylation sites using site-directed mutagenesis

  • Analyze mutant proteins with SPAC20G4.08 antibody to confirm altered glycosylation

  • Assess functional consequences through phenotypic analysis (septum formation, cell wall integrity)

• Co-localization Studies:

  • Perform dual-labeling immunofluorescence with SPAC20G4.08 antibody and markers for:

    • Cell wall components (β-1,3-glucan, α-1,3-glucan, chitin)

    • Golgi apparatus (where glycosylation occurs)

    • Secretory pathway components

  • Use high-resolution microscopy (e.g., structured illumination, STED) for detailed co-localization analysis

• Interaction Partner Identification:

  • Conduct co-immunoprecipitation experiments using SPAC20G4.08 antibody to isolate Sup11p complexes

  • Analyze precipitated proteins by mass spectrometry to identify interaction partners

  • Validate interactions using reciprocal co-immunoprecipitation or proximity ligation assays

  • Focus particularly on interactions with glucan-modifying enzymes like Gas2p

• Stress Response Analysis:

  • Expose cells to cell wall stressors (e.g., Calcofluor White, Congo Red)

  • Monitor changes in Sup11p glycosylation patterns using SPAC20G4.08 antibody

  • Correlate glycosylation changes with transcriptional responses (e.g., upregulation of gas2+)

This comprehensive approach enables researchers to dissect the complex relationship between Sup11p glycosylation and its role in maintaining cell wall integrity.

What are the considerations for using SPAC20G4.08 antibody in cross-species studies of cell wall biogenesis?

When using SPAC20G4.08 antibody for cross-species studies of cell wall biogenesis:

• Sequence Homology Assessment:

  • Perform bioinformatic analysis to identify homologs of SPAC20G4.08/sup11+ in other fungal species

  • Focus particularly on the conserved leucine-rich repeat (LRR) domains that characterize Sup11p

  • Evaluate percent identity and similarity, particularly in epitope regions

• Epitope Conservation Analysis:

  • Identify the specific epitope(s) recognized by the SPAC20G4.08 antibody

  • Assess conservation of these epitopes across species using multiple sequence alignment

  • For polyclonal antibodies, recognize that they may detect multiple epitopes with varying conservation

• Preliminary Cross-Reactivity Testing:

  • Perform western blotting with protein extracts from different fungal species

  • Include positive (S. pombe) and negative controls

  • Start with higher antibody concentrations (1:100-1:500) when testing new species

  • Look for bands at the predicted molecular weight of the homologous protein

• Validation in Non-Model Species:

  • For species where cross-reactivity is observed, validate specificity using:

    • Knockout/knockdown strains of the homologous gene

    • Heterologous expression of the S. pombe SPAC20G4.08 as a positive control

    • Peptide competition assays to confirm epitope specificity

• Comparative Cell Wall Analysis:

  • Once validated, use the antibody to compare:

    • Protein localization patterns during septum formation

    • Glycosylation states across species

    • Protein levels in response to cell wall stressors

  • Correlate findings with known differences in cell wall composition between species

This methodical approach allows researchers to leverage SPAC20G4.08 antibody beyond S. pombe, potentially providing evolutionary insights into conserved mechanisms of fungal cell wall biogenesis.

What are common issues encountered with SPAC20G4.08 antibody and how can they be resolved?

Researchers often encounter several challenges when working with SPAC20G4.08 antibody. Here are common issues and their solutions:

• Weak or No Signal in Western Blotting:

  • Potential Causes: Insufficient protein, antibody degradation, inefficient transfer

  • Solutions:

    • Increase protein loading (start with 30-50 μg total protein)

    • Try a fresh antibody aliquot or increase concentration (1:500 instead of 1:1000)

    • Optimize transfer conditions for high molecular weight glycoproteins

    • Include positive controls (wild-type S. pombe extract)

    • Consider using enhanced chemiluminescence substrates with higher sensitivity

• Multiple Unexpected Bands:

  • Potential Causes: Protein degradation, cross-reactivity, post-translational modifications

  • Solutions:

    • Include protease inhibitors in sample preparation

    • Perform peptide competition assays to identify specific versus non-specific bands

    • Use glycosidase treatments to confirm glycoform-specific bands

    • Compare with patterns from mutant strains to identify specific modifications

• Inconsistent Immunofluorescence Results:

  • Potential Causes: Fixation issues, antibody batch variation, cell wall permeabilization problems

  • Solutions:

    • Optimize fixation protocol (try different fixatives or combinations)

    • Add a cell wall digestion step with zymolyase or lysing enzymes before antibody incubation

    • Extend primary antibody incubation time (overnight at 4°C)

    • Use signal amplification methods (e.g., tyramide signal amplification)

• Poor Reproducibility Between Experiments:

  • Potential Causes: Antibody degradation, variation in cell growth conditions, inconsistent sample preparation

  • Solutions:

    • Standardize growth conditions (media, temperature, growth phase)

    • Prepare larger batches of antibody working dilutions to use across experiments

    • Include internal loading controls in western blots

    • Document detailed protocols for each step of sample preparation

• High Background in Immunodetection:

  • Potential Causes: Insufficient blocking, high antibody concentration, non-specific binding

  • Solutions:

    • Extend blocking time (2-3 hours at room temperature)

    • Try alternative blocking agents (5% BSA instead of milk)

    • Increase washing steps (5×5 minutes with TBST)

    • Dilute antibody in blocking buffer with 0.1% Tween-20

    • Pre-adsorb antibody with acetone powder from knockout strains

Implementing these solutions systematically can help overcome technical challenges and improve experimental outcomes when working with SPAC20G4.08 antibody.